methotrexate has been researched along with Arachnoid Cysts in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pavlidis, N; Pentheroudakis, G | 1 |
| Akerley, W; Calabresi, P; Cole, BF; Egorin, MJ; Glantz, MJ; Hochberg, F; Mills, P; Recht, L; Saris, S | 1 |
1 review(s) available for methotrexate and Arachnoid Cysts
| Article | Year |
|---|---|
Management of leptomeningeal malignancy.
Topics: Adenocarcinoma; Algorithms; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Arachnoid Cysts; Carcinoma; Combined Modality Therapy; Cranial Irradiation; Cytarabine; Delayed-Action Preparations; Enzyme Inhibitors; Humans; Injections, Intravenous; Injections, Spinal; Leukemia; Lymphoma; Meningeal Neoplasms; Methotrexate; Palliative Care; Randomized Controlled Trials as Topic; Thiotepa; Topoisomerase I Inhibitors; Topotecan | 2005 |
1 trial(s) available for methotrexate and Arachnoid Cysts
| Article | Year |
|---|---|
High-dose intravenous methotrexate for patients with nonleukemic leptomeningeal cancer: is intrathecal chemotherapy necessary?
Topics: Adult; Antimetabolites, Antineoplastic; Arachnoid Cysts; Female; Humans; Infusions, Intravenous; Injections, Spinal; Male; Methotrexate; Middle Aged; Neoplasms; Survival Analysis | 1998 |